Basics Relmada Therapeutics, Inc. IPO Date: June 16, 2014 Sector: Healthcare Industry: Biotech Market Cap: $21.97M Activated in VL: True Average Daily Range Avg Daily Range: $0.56 | 3.70% Avg Daily Range (30 D): $0.06 | 12.39% Avg Daily Range (90 D): $0.04 | 8.50% Institutional Daily Volume Avg Daily Volume: .31M Avg Daily Volume (30 D): 2.62M Avg Daily Volume (90 D): 1.38M Trade Size Avg Trade Size (Sh.): 133 Avg Trade Size (Sh.) (30 D): 602 Avg Trade Size (Sh.) (90 D): 577 Institutional Trades Total Inst.Trades: 365 Avg Inst. Trade: $2.13M Avg Inst. Trade (30 D): $.6M Avg Inst. Trade (90 D): $.6M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.27M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 102.03K         News Apr 28, 2025 @ 5:38 PM Relmada Therapeutics Presents Positive Initial Pha... Source: N/A Apr 27, 2025 @ 1:00 PM UPDATE -- Relmada Therapeutics To Present NDV-01 D... Source: N/A Feb 25, 2025 @ 6:00 PM Comprehensive Market Analysis of Latest Published ... Source: Delveinsight Dec 9, 2024 @ 12:30 PM Relmada Therapeutics to Discontinue the Reliance I... Source: Globe Newswire Feb 1, 2024 @ 1:42 PM Relmada Therapeutics And 2 Other Penny Stocks Insi... Source: Avi Kapoor Financials   TTM Q4 2024 FY 2024 Basic EPS $-.58 $-.62 $-2.65 Diluted EPS $-.58 $-.62 $-2.65 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -17.56M $ -18.66M $ -79.98M Operating Income / Loss $ -18.22M $ -19.08M $ -83.89M Cost of Revenue $ $ $ Net Cash Flow $ M $ 2.37M $ -.23M PE Ratio     Splits Sep 30, 2019:   1:4 Aug 12, 2015:   1:5